organization · Reporting owner
Puissance Cross-Border Opportunities IV LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Tracon Pharmaceuticals, Inc.
Report date December 05, 2019 · Filed December 11, 2019
Jointly reported with Puissance Cross-Border Opportunities V LLC, Puissance Capital Management LP, Puissance Capital Fund (GP) LLC, Puissance Capital Management (GP) LLC, Wang Theodore T
Section 16 reporting ended · disclosed 2019-12-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy funds | 416,182 |
Reported balance
After 2019-12-05 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2019-12-05 · Sale · Disposed 43,996 · Balance 416,182 F1: Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 43,996 shares of common stock. F2: Consists of: 239,190 Shares directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Shares directly owned Puissance Cross-Border Opportunities IV LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy funds | 76,048 |
Reported balance
After 2019-12-09 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2019-12-09 · Sale · Disposed 340,134 · Balance 76,048 F3: Puissance Cross-Border Opportunities IV LLC made an in-kind distribution of 176,992 shares of common stock. Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 163,142 shares of common stock. F4: Consists of: 76,048 Shares directly owned by Puissance Cross-Border Opportunities V LLC. |
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.00 · Expires 2024-03-27 | IndirectBy funds | 460,178 |
Reported balance
Holding disclosure · report date 2019-12-05 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 460,178 F5: Consists of: 283,186 Warrants directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Warrants directly owned Puissance Cross-Border Opportunities IV LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 43,996 shares of common stock.
F2: Consists of: 239,190 Shares directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Shares directly owned Puissance Cross-Border Opportunities IV LLC.
F3: Puissance Cross-Border Opportunities IV LLC made an in-kind distribution of 176,992 shares of common stock. Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 163,142 shares of common stock.
F4: Consists of: 76,048 Shares directly owned by Puissance Cross-Border Opportunities V LLC.
F5: Consists of: 283,186 Warrants directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Warrants directly owned Puissance Cross-Border Opportunities IV LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2019 Filed Dec 11, 2019 10:47 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | SaleCommon Stock | 340,134 | $2.92 | $993,191.28 |
DisclosureSEC source: 0001733439-19-000001 · primary_doc.xml · nonDerivative · entry 2 Puissance Cross-Border Opportunities V LLC · CIK 0001733439 · 10% owner Puissance Cross-Border Opportunities IV LLC · CIK 0001718140 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Wang Theodore T · CIK 0001694061 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 76,048 F3 · shares: Puissance Cross-Border Opportunities IV LLC made an in-kind distribution of 176,992 shares of common stock. Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 163,142 shares of common stock. F4 · ownership.direct: Consists of: 76,048 Shares directly owned by Puissance Cross-Border Opportunities V LLC. Read SEC document |
| December 05, 2019 Filed Dec 11, 2019 10:47 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | SaleCommon Stock | 43,996 | $3.05 | $134,187.80 |
DisclosureSEC source: 0001733439-19-000001 · primary_doc.xml · nonDerivative · entry 1 Puissance Cross-Border Opportunities V LLC · CIK 0001733439 · 10% owner Puissance Cross-Border Opportunities IV LLC · CIK 0001718140 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Wang Theodore T · CIK 0001694061 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 416,182 F1 · shares: Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 43,996 shares of common stock. F2 · ownership.direct: Consists of: 239,190 Shares directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Shares directly owned Puissance Cross-Border Opportunities IV LLC. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 10:14 UTC Amendment | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | SaleCommon Stock | 4,326 | $1.21 | $5,234.46 |
DisclosureSEC source: 0001733439-18-000016 · primary_doc.xml · nonDerivative · entry 2 Puissance Cross-Border Opportunities V LLC · CIK 0001733439 · 10% owner Puissance Cross-Border Opportunities IV LLC · CIK 0001718140 · 10% owner Puissance Life Science Opportunities Fund VI · CIK 0001760460 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Wang Theodore T · CIK 0001694061 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 4,601,768 F4 · ownership.direct: The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 10:14 UTC Amendment | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | PurchaseCommon Stock | 4,326 | $1.13 | $4,888.38 |
DisclosureSEC source: 0001733439-18-000016 · primary_doc.xml · nonDerivative · entry 1 Puissance Cross-Border Opportunities V LLC · CIK 0001733439 · 10% owner Puissance Cross-Border Opportunities IV LLC · CIK 0001718140 · 10% owner Puissance Life Science Opportunities Fund VI · CIK 0001760460 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Wang Theodore T · CIK 0001694061 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 4,606,094 F4 · ownership.direct: The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 09:39 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | SaleCommon Stock | 4,326 | $1.21 | $5,234.46 |
DisclosureSEC source: 0001733439-18-000015 · primary_doc.xml · nonDerivative · entry 2 Puissance Cross-Border Opportunities V LLC · CIK 0001733439 · 10% owner Puissance Cross-Border Opportunities IV LLC · CIK 0001718140 · 10% owner Puissance Life Science Opportunities Fund VI · CIK 0001760460 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Wang Theodore T · CIK 0001694061 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 4,601,768 F4 · ownership.direct: The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 09:39 UTC | Tracon Pharmaceuticals, Inc. TCON · Entity 91134 | PurchaseCommon Stock | 4,326 | $1.13 | $4,888.38 |
DisclosureSEC source: 0001733439-18-000015 · primary_doc.xml · nonDerivative · entry 1 Puissance Cross-Border Opportunities V LLC · CIK 0001733439 · 10% owner Puissance Cross-Border Opportunities IV LLC · CIK 0001718140 · 10% owner Puissance Life Science Opportunities Fund VI · CIK 0001760460 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Wang Theodore T · CIK 0001694061 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 4,606,094 F4 · ownership.direct: The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.